AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, will attend the Jefferies Global Healthcare Conference in London from 17 to 20 ...

The Labaid Group is developing AI-based healthtech solutions and plans to establish 30 satellite cancer centres across Bangladesh to usher in a more precise healthcare. In an interview with The ...

Former President Joe Biden has completed a course of radiation therapy after being diagnosed in May with an "aggressive form" of prostate cancer, according to a spokesperson. Biden's daughter Ashley ...

Former President Joseph R. Biden Jr. began radiation therapy last month for an aggressive form of prostate cancer. It is unclear if his treatment has ended. By Yan Zhuang and Reid J. Epstein Former ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

Former President Joe Biden completed a round of radiation treatment for his aggressive form of prostate cancer on Monday. Biden had been undergoing treatment at Penn Medicine Radiation Oncology in ...

Ed O'Keefe is CBS News' senior White House and political correspondent reporting for all CBS News platforms. He's part of the team covering President Trump and covered all four years of Joe Biden's ...

Former President Joe Biden completed a course of radiation therapy to treat his prostate cancer on Monday. Biden’s daughter, Ashley, shared a video of him ringing the bell at Penn Medicine Radiation ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of radiation treatment Monday, his office said. Biden underwent several weeks of ...

Biden, 82, celebrated the milestone at Penn Medicine Radiation Oncology in Philadelphia by taking part in the traditional ringing of the bell, a ritual that marks the end of treatment for a cancer ...

Former President Joe Biden has completed a round of radiation therapy for an aggressive form of prostate cancer. The 82-year-old finished several weeks of therapy at Penn Medicine Radiation Oncology ...